Market revenue in 2023 | USD 178.3 million |
Market revenue in 2030 | USD 294.6 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Cardiac was the largest segment with a revenue share of 46.38% in 2023. Horizon Databook has segmented the Global cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of lifestyle-associated diseases has been increasing rapidly in developing countries in the last few years. Thus, the demand for healthcare services for lifestyle-associated diseases, such as diabetes, cardiovascular diseases, cancer, is anticipated to increase, thereby driving market growth. Conditions such as diabetes mellitus, obesity, hypertension, and dyslipidemia are major risk factors for cardiovascular diseases.
In the UK, lifestyle-related diseases such as diabetes, cancer, and heart disease account for 90% of deaths each year. Cardiac arrhythmia, hypertension, ischemic conditions, sleep apnea, diabetes, hyperlipidemia, asthma, and chronic obstructive pulmonary disease are other chronic conditions that are reported globally. Such rise in cases of lifestyle-related disorders is anticipated to fuel market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account